Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Genetic Polymorphisms on the Clinical Response to Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors in Prevention of Cardiac Remodeling and Fibrosis in Heart Failure Patients

NCT06201000 is registered in ClinicalTrials.gov with October 6 University as lead sponsor.

NCT NCT06201000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06201000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Genetic Polymorphisms on the Clinical Response to Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors in Prevention of Cardiac Remodeling and Fibrosis in Heart Failure Patients
Lead sponsor
October 6 University
Phase
Observational
Overall status
Unknown status
Start date
December 27, 2023
Completion date
September 1, 2024
Enrollment
282 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genetic polymorphisms, heart failure